Chatham Capital Group Inc. Sells 1,555 Shares of Maximus, Inc. (NYSE:MMS)

Chatham Capital Group Inc. reduced its stake in shares of Maximus, Inc. (NYSE:MMS) by 4.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 33,902 shares of the health services provider’s stock after selling 1,555 shares during the quarter. Chatham Capital Group Inc. owned 0.06% of Maximus worth $2,531,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Geode Capital Management LLC grew its stake in shares of Maximus by 1.4% during the third quarter. Geode Capital Management LLC now owns 1,525,159 shares of the health services provider’s stock valued at $142,109,000 after buying an additional 21,532 shares during the last quarter. Van Berkom & Associates Inc. grew its stake in shares of Maximus by 8.5% during the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider’s stock valued at $93,792,000 after buying an additional 98,264 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Maximus by 7.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider’s stock valued at $74,700,000 after buying an additional 71,598 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Maximus by 2.4% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 722,172 shares of the health services provider’s stock worth $54,748,000 after purchasing an additional 16,772 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its stake in shares of Maximus by 8.2% in the fourth quarter. Bank of New York Mellon Corp now owns 570,740 shares of the health services provider’s stock worth $42,606,000 after purchasing an additional 43,421 shares during the last quarter. 97.21% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This trade represents a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Raymond B. Ruddy bought 3,490 shares of the stock in a transaction dated Thursday, December 12th. The shares were acquired at an average price of $71.46 per share, with a total value of $249,395.40. Following the completion of the acquisition, the director now directly owns 112,520 shares of the company’s stock, valued at approximately $8,040,679.20. The trade was a 3.20 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased 7,008 shares of company stock worth $497,835 over the last three months. Company insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

MMS has been the topic of several recent analyst reports. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a research note on Thursday, January 2nd. StockNews.com cut Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th.

Maximus Stock Down 0.0 %

NYSE MMS opened at $67.97 on Friday. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The stock has a market capitalization of $3.85 billion, a PE ratio of 14.62 and a beta of 0.72. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The business’s 50-day moving average is $72.91 and its 200 day moving average is $80.49.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Sell-side analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were issued a $0.30 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.77%. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.